UC San Francisco’s Health eHeart Study – an ambitious technology-based cardiovascular research study – has garnered the support from the American Heart Association, the largest U.S. non-profit organization dedicated to reducing disability and deaths caused by cardiovascular disease and stroke.
December 06, 2013
November 06, 2012
Hospitalized heart failure patients who received the drug, serelaxin, in a phase III clinical trial had fewer disease symptoms and as a group experienced 37 percent fewer deaths over six months, according to results of a new study.
August 16, 2012
It’s become common practice for the roughly 6 million Americans per year who go to emergency rooms with chest pain: Get a stress test or cardiac CT (computed tomography) scan before discharge.
May 14, 2012
What is the connection, if any, between sudden cardiac death and people with HIV/AIDS? And can that knowledge help prolong their lives?
November 04, 2011
UCSF was recently recognized as a 2011 gold-level recipient of the American Heart Association’s Start! Fit-Friendly Companies Recognition program.
May 04, 2011
Blending state-of-the art technology and cutting-edge design, UCSF’s new cardiovascular research building at Mission Bay integrates basic and clinical research to address important questions in cardiovascular biology and disease.
February 03, 2011
UCSF Nobel laureate Elizabeth Blackburn is not ready to predict how long you will live. But she and her UCSF colleagues are exploring a feature within cells that is a kind of hourglass for aging.
November 03, 2010
Paul Simpson, a cardiologist at the San Francisco VA Medical Center and a professor of medicine at UCSF, has been named the 2010 Thomas Smith Memorial Lecturer by the American Heart Association.
August 03, 2010
Testosterone in men has become a hot health topic. New studies, including one by UCSF researchers, now are sparking a controversy over the role of testosterone in heart disease.
June 24, 2010
The oil spill crisis in the Gulf Coast underscores the importance of implementing effective regulation through a proactive strategy to protect public health, according to UCSF’s Paul Blanc, the author of a re-released book.